Clinical Trial Update: Tavo and Pembrolizumab With or Without Chemotherapy in Patients With Inoperable Locally Advanced or Metastatic TNBC [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating Tavo (talimogene laherparepvec) and pembrolizumab with or without chemotherapy in inoperable locally advanced or metast…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Triple-negative Breast Cancer

Drugs mentioned

• Pembrolizumab (pembrolizumab)
• Tavo

Snippet

Sponsor: OncoSec Medical Incorporated | Conditions: Triple Negative Breast Cancer | Phase 2 | Status: UNKNOWN